Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Healthcare Drug Manufacturers - Major Cannabis
Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Nova Mentis Life Science Corp. > American holdings
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by JRfishonon Dec 10, 2017 9:11pm
140 Views
Post# 27128089

RE:RE:RE:RE:RE:American holdings

RE:RE:RE:RE:RE:American holdings I agree on MPX Bioceutical in regards to undervalued with revenues close to Aphria , Isodiol and more than CanniMed last quater. Once all plans executed and Licence issued for their facily in Owen Sound Ontario the SP will take off....It is just a matter of time and I am long on MPX. 
Check out link video from CEO Scott Boyes....until then I am excited about LIB and feel we will be a an uptrend this week!

https://youtu.be/X71ws4A8Ks4

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities